Cancer doesn’t stop because of COVID-19 and Isoray CEO Lori Woods says the company took early action to stay ahead of the pandemic. Here’s what she told WCBS’s CEO Radio about protecting access to Cesium-131 brachytherapy.
Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session
The result from first patient dosed with VMT-α-NET in India on a compassionate use basis showed favorable responses. The initial response was...
